Research and Development

Our R&D efforts are focused on developing innovative therapies and technologies that address unmet medical needs. With a strong pipeline of projects and a dedicated team of scientists, we are advancing the frontiers of biotechnology.

We are proud to have executed a collaborative research agreement with Cryopraxis, Brazil’s largest and pioneer cord blood bank. This partnership leverages Cryopraxis’ extensive experience and resources in cord blood banking, enabling us to access high-quality NK cells for our research. Together, we are exploring innovative treatments that harness the power of NK cells to improve patient outcomes.

Cord Blood and NK Cells One of the most valuable sources of Natural Killer (NK) cells is cord blood. NK cells play a crucial role in the immune system, particularly in combating cancer and viral infections. Recognizing the potential of NK cells derived from cord blood, BioNK has prioritized research in this area to develop groundbreaking therapies.

Cord Blood derived NK cell, naïve or sourced from CD34+ are within BioNKc’s scope of collaboration with Cryopraxis.